Cationic liposomes (CLs) are effective carriers of a variety of therapeutics. Their applications
as vectors of nucleic acids (NAs), from long DNA and mRNA to short interfering RNA …

Since the discovery of the first microRNAs (miRNAs, miRs), the understanding of miRNA
biology has expanded substantially. miRNAs are involved and described as master …

Gene therapy is becoming an influential part of the rapidly increasing armamentarium of
biopharmaceuticals for improving health and combating diseases. Currently, three gene …

Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases
expected for 2040. Despite de advances in the treatment, it remains a challenge because of …

A stable phase of toroidal, or ringlike, supramolecular assemblies was formed by combining
dilute solution characteristics critical for both bundling of like-charged biopolymers and block …

There has been keen interest in the development of a novel drug delivery system. Novel
drug delivery system aims to deliver the drug at a rate directed by the needs of the body …

Cationic lipid-mediated gene transfer is widely used for their advantages over viral gene
transfer because it is non-immunogenic, easy to produce and not oncogenic. The main …

Cationic lipids are widely used for gene delivery, and inclusion of
dioleoylphosphatidylethanolamine (DOPE) as a helper lipid in cationic lipid–DNA …

The cell therapy industry has grown rapidly over the past 3 decades, and multiple clinical
trials have been performed to date covering a wide range of diseases. The most frequently …

Gene therapy is expected to treat various incurable diseases including viral infections,
autoimmune disorders, and cancers. Cationic lipids (CL) have been used as carriers of …